We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
British drugmaker Acambis has signed a partnership agreement with French vaccine company sanofi pasteur, a subsidiary of sanofi-aventis, for ChimeriVax-JE, Acambis' single-dose vaccine against Japanese encephalitis.
A hearing began today in an Indian court in which Novartis is seeking to "gain clarity" on the country's laws regarding the protection of intellectual property, the company announced.
The Pan American Health Organization will be able to purchase large amounts of GlaxoSmithKline's (GSK) rotavirus vaccine for use in mass vaccination programs now that the shot has been awarded prequalification status by the World Health Organization (WHO).
The European Union (EU) has adopted a new international agreement that will eliminate customs duties on many new pharmaceutical products among major drug-trading nations.
Guangdong Lantai Viewland Pharmaceutical, based in China, has signed a licensing agreement with Medivir for the rights to MIV-160, a non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV in late preclinical development.
GlaxoSmithKline (GSK) has launched a new pediatric vaccine in South Africa, according to an article published a daily Cape Town-based newspaper, the Cape Argus.
Starpharma Holdings has signed an agreement with the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Child Health and Human Development to fund a clinical trial of the microbicide VivaGel.